EverHint – Breakout Ultra Tight – Top 3 Signals for Jul 08, 2026
What This Signal Is
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
Market Context
Markets are showing a mixed but cautious tone heading into July 8, 2026, with notable divergence across major indices. The Dow Jones is leading the decline at -1.09%, while the Nasdaq is managing a modest gain of +0.19%, suggesting investors are rotating away from value and dividend-heavy names toward growth and technology exposure. The S&P 500's slight dip of -0.29% reflects a broadly neutral to slightly defensive posture, with no clear directional conviction across the broader market. This kind of index divergence can create fertile ground for momentum-swing strategies, as individual sectors and stocks tend to move independently rather than in lockstep.
The VIX reading of 16.59, up nearly 3% on the day, is worth watching closely. While still within a historically moderate range, the uptick signals that options markets are pricing in slightly elevated near-term uncertainty. For momentum-swing signals, this is a double-edged environment — intraday price ranges may widen, offering better entry and exit opportunities, but stop-loss levels may need to be set with a bit more breathing room to avoid being shaken out by noise. Traders should be mindful that momentum moves can accelerate quickly in this volatility regime but can also reverse sharply.
Healthcare emerging as the top sector for today's signals aligns well with the current risk-off undertones visible in the Dow's underperformance. Healthcare tends to attract capital during periods of uncertainty as a defensive rotation play, which could provide underlying support for momentum setups in this space. The combination of selective growth appetite (evidenced by Nasdaq resilience) and a mild defensive shift creates a reasonable backdrop for swing trades that target sector-specific momentum rather than broad market beta.
📊 Signals (3 of 3 total)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | SNDX | Syndax Pharmaceuticals... | Healthcare | $24.56 | 1.00 | — | $2.2B |
| 2 | FR | First Industrial Realt... | Real Estate | $64.64 | 0.35 | — | $8.6B |
| 3 | XENE | Xenon Pharmaceuticals ... | Healthcare | $69.95 | 0.15 | -$310,575 | $5.5B |
Field Notes
Sector concentration: Healthcare (2), Real Estate (1)
Insider selling: XENE (Xenon Pharmaceuticals Inc., -$310,575)
Data coverage: 33.3% insider, 0.0% congressional, 0.0% earnings, 0.0% news
Peer Analysis
FR (First Industrial Realty Trust, Inc.): Leads 5 peers: STAG ($38.60), VNO ($38.06), CTRE ($41.34), CUBE ($39.94), REXR ($33.92)
XENE (Xenon Pharmaceuticals Inc.): Leads 5 peers: APGE ($133.25), AAPG ($18.86), RARE ($34.67), CELC ($108.90), ZLAB ($19.75)
SNDX (Syndax Pharmaceuticals, Inc.): Leads 5 peers: RLAY ($19.63), INBX ($97.10), AMLX ($17.88), ORIC ($10.90), NKTR ($71.90)
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.